What is WST's current stock price?

As of now, WST is trading at $302.04, with a daily change of -1.69%.

What are the risks associated with WST stock?

WST Key risk is its Moderate Risk Level, .

What is WST next earnings date?

WST next earnings report is scheduled for Oct 23, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

WST Stock Analysis & IQ Rating | West Pharmaceutical

WST

West Pharmaceutical

$302.04

-$5.18 | -1.69%

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 348.9

MKT CAP

$ 21.72B

52W Low

$ 187.43

VOL

$ 306.69K

P/E Ratio

44.75

AVG VOL

$ 698.01K

RSI

76.80

TREND

Sideways

WST Stock IQ

Login to see West Pharmaceutical (WST) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

WST Target Price

Login to display

Strengths

WST Rewards

Earnings are forecast to grow

WST Rewards

Upgraded on attractively valued

Chart

$262.33 (+15.14%)

$244.05 (+23.76%)

$211.45 (+42.84%)

$323.93 (-6.76%)

1year

6month

3month

1month

WST Risk Level

WST has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

LOW

HIGH

WST Analysts Opinion

WST overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

WST Analysts Opinion

WST Analysts opinion is negative and has getting worse from the past 3 months

WST Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

83%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

83%

70%

WST Street Opinion

WST Street view is extremely bullish and have positive views on the near-term outlook

WST Performance Sentiment

Sentiments overview associated with WST events and the stock performance.

83%

17%

Positive

Negative

24 out of 29
events present

5 out of 29
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

WST Earnings

The TTM reflects 12-month period, providing review of WST financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

2,960

2,893

2,950

+0.17%

Cost of Revenue

1,916

1,895

1,821

+2.58%

Gross Profit

1,044

999

1,129

-3.84%

Operating Exp

422

408

422

-

Operating Inc

622

591

707

-6.20%

Net Interest Inc

17

19

-5.41%

Interest Exp

3

9

-

Interest Inc

17

20

28

-22.08%

Other Inc Exp

-42

-22

-28

-

EPS Growth

6.72

6.75

7.98

-8.23%

WST Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

2.82

Next Earnings Date: Oct 23, 2025

WST Latest Analysis +

West Pharmaceutical Services Inc. (NYSE:WST) Q3 2025 Earnings Call Transcript. West Pharmaceutical Services Inc. (NYSE:WST) Q3 2025 Earnings Call Transcript October 23 2025 West Pharmaceutical Services Inc. beats earnings expectations. Reported EPS is $1.96 expectations were $1.67. Operator: Good day and welcome to West’.s Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder this call may be recorded. I would now like to [….]

Today

$302.04 | -1.69%

Earnings

Evercore ISI Group Maintains West Pharmaceutical Services (WST) Outperform Recommendation. Fintel reports that on October 23 2025 Evercore ISI Group maintained coverage of West Pharmaceutical Services (NYSE:WST) with a Outperform recommendation. Analyst Price Forecast Suggests 4.22% Upside

Today

$302.04 | -1.69%

Rating

West to Participate in Upcoming Investor Conferences. EXTON Pa. Oct. 24 2025 /PRNewswire/ -- West Pharmaceutical Services Inc. (NYSE: WST) a global leader in innovative solutions for injectable drug administration today announced that it will present at the following upcoming investor conferences: UBS Global Healthcare Conference:...

Today

$302.04 | -1.69%

Activity

Why West Pharmaceutical Services Stock Was Blasting Higher on Thursday. Key PointsIt was a beat-and-raise third quarter for the healthcare services specialist.

Thu Oct 23, 2025

$307.25 | +11.01%

Momentum

West Pharmaceutical raises 2025 EPS guidance to $7.06-$7.11 amid strong HVP Components growth.

Thu Oct 23, 2025

$307.25 | +11.01%

Potential

West Pharma Soars After Q3 Beat Lifts Outlook On GLP-1 Demand. WST) shares surged Thursday after the injectable pharmaceutical packaging and delivery systems company’.s third-quarter 2025 earnings surpassed analyst estimates.West Pharmaceutical reported adjusted earnings of $1.96 per share beating the consensus of $1.68.Net sales of $804.6 million increased 7.7% year over year with organic growth was 5.0% beating the consensus of $787.93 million.“.Our strength was broad-based across bo

Thu Oct 23, 2025

$307.25 | +11.01%

Momentum

Potential

S&P 500 Movers: MOH WST. In early trading on Thursday shares of West Pharmaceutical Services topped the list of the days best performing components of the S&.P 500 index trading up 15.5%. Year to date West Pharmaceutical Services has lost about 2.3% of its value.And the worst performing S&

Thu Oct 23, 2025

$307.25 | +11.01%

Momentum

WST Stock Up on Q3 Earnings Beat EPS View Raised on Demand & FX Benefit. West Pharmaceuticals strong Q3 beat and raised EPS outlook highlight robust demand FX tailwinds and solid growth in Proprietary Products.

Thu Oct 23, 2025

$307.25 | +11.01%

Earnings

Momentum

Potential

West Pharmaceutical Non-GAAP EPS of $1.96 beats by $0.27 revenue of $804.6M beats by $16.9M.

Thu Oct 23, 2025

$307.25 | +11.01%

Earnings

West Reports Third-Quarter 2025 Results. - Delivered solid growth across Proprietary Products and Contract Manufacturing Segments - - Achieved double-digit growth in HVP Components -- Strengthened executive leadership team including recently appointed CFO - Increases Full-Year 2025 Revenue and EPS Guidance - Third-Quarter Summary (comparisons to prior-year period)Net sales of Diluted EPS of Adjusted-diluted EPS of Full-year 2025 net sales guidance increased to a range of Full-year 2025 adjust

Thu Oct 23, 2025

$307.25 | +11.01%

Activity

Potential

FAQ About WST Stock Insights

What is WST current stock price?

What are WST stock strengths?

What risks are associated with WST stock?

When is WST next earnings report?

What is WST market cap and volume?

What is WST's current Stock IQ?

Should I buy WST stock right now?

Is WST a Strong Buy right now?

What does a 'Strong Buy' rating mean for WST?

What does a 'Strong Sell' rating mean for WST?

What factors influence WST's Stock IQ?

Explore our WST Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored WST Stock Strategies
Effective Risk Management

FIND US ON

Receive our WST Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

WST

West Pharmaceutical

Current Price

$302.04

-$5.18 | -1.69%

52W High

$ 348.9

MKT CAP

$ 21.72B

52W Low

$ 187.43

VOL

$ 306.69K

P/E Ratio

44.75

AVG VOL

$ 698.01K

RSI

76.80

TREND

Sideways

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

WST Rewards

Earnings are forecast to grow

WST Rewards

Upgraded on attractively valued

WST Stock IQ

Login to unlock West Pharmaceutical (WST) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$262.33 (+15.14%)

$244.05 (+23.76%)

$211.45 (+42.84%)

$323.93 (-6.76%)

1year

6month

3month

1month

WST Analysts Opinion

WST Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

WST Analysts Opinion

WST Analysts opinion is negative and has getting worse from the past 3 months

WST Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

83%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

83%

70%

WST Street Opinion

WST Street view is extremely bullish and have positive views on the near-term outlook

WST Risk Level

WST has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

LOW

HIGH

WST Performance Sentiment

Sentiments overview associated with WST events and the stock performance.

83%

17%

Positive

Negative

24 out of 29
events present

5 out of 29
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

WST Earnings

The TTM data reflects the most recent 12-month period, providing overview of WST financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

2,960

2,893

2,950

+0.17%

Cost of Revenue

1,916

1,895

1,821

+2.58%

Gross Profit

1,044

999

1,129

-3.84%

Operating Exp

422

408

422

-

Operating Inc

622

591

707

-6.20%

Net Interest Inc

17

19

-5.41%

Interest Exp

3

9

-

Interest Inc

17

20

28

-22.08%

Other Inc Exp

-42

-22

-28

-

EPS Growth

6.72

6.75

7.98

-8.23%

WST Financial Health

The company financial health has shown minor improvement, but significant issues remain

Financial Score

2.82

Next Earnings Date: Oct 23, 2025

WST Latest Analysis

West Pharmaceutical Services Inc. (NYSE:WST) Q3 2025 Earnings Call Transcript. West Pharmaceutical Services Inc. (NYSE:WST) Q3 2025 Earnings Call Transcript October 23 2025 West Pharmaceutical Services Inc. beats earnings expectations. Reported EPS is $1.96 expectations were $1.67. Operator: Good day and welcome to West’.s Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder this call may be recorded. I would now like to [….]

Today

$302.04 | -1.69%

Earnings

Evercore ISI Group Maintains West Pharmaceutical Services (WST) Outperform Recommendation. Fintel reports that on October 23 2025 Evercore ISI Group maintained coverage of West Pharmaceutical Services (NYSE:WST) with a Outperform recommendation. Analyst Price Forecast Suggests 4.22% Upside

Today

$302.04 | -1.69%

Rating

West to Participate in Upcoming Investor Conferences. EXTON Pa. Oct. 24 2025 /PRNewswire/ -- West Pharmaceutical Services Inc. (NYSE: WST) a global leader in innovative solutions for injectable drug administration today announced that it will present at the following upcoming investor conferences: UBS Global Healthcare Conference:...

Today

$302.04 | -1.69%

Activity

Why West Pharmaceutical Services Stock Was Blasting Higher on Thursday. Key PointsIt was a beat-and-raise third quarter for the healthcare services specialist.

Thu Oct 23, 2025

$307.25 | +11.01%

Momentum

West Pharmaceutical raises 2025 EPS guidance to $7.06-$7.11 amid strong HVP Components growth.

Thu Oct 23, 2025

$307.25 | +11.01%

Potential

West Pharma Soars After Q3 Beat Lifts Outlook On GLP-1 Demand. WST) shares surged Thursday after the injectable pharmaceutical packaging and delivery systems company’.s third-quarter 2025 earnings surpassed analyst estimates.West Pharmaceutical reported adjusted earnings of $1.96 per share beating the consensus of $1.68.Net sales of $804.6 million increased 7.7% year over year with organic growth was 5.0% beating the consensus of $787.93 million.“.Our strength was broad-based across bo

Thu Oct 23, 2025

$307.25 | +11.01%

Momentum

Potential

S&P 500 Movers: MOH WST. In early trading on Thursday shares of West Pharmaceutical Services topped the list of the days best performing components of the S&.P 500 index trading up 15.5%. Year to date West Pharmaceutical Services has lost about 2.3% of its value.And the worst performing S&

Thu Oct 23, 2025

$307.25 | +11.01%

Momentum

WST Stock Up on Q3 Earnings Beat EPS View Raised on Demand & FX Benefit. West Pharmaceuticals strong Q3 beat and raised EPS outlook highlight robust demand FX tailwinds and solid growth in Proprietary Products.

Thu Oct 23, 2025

$307.25 | +11.01%

Earnings

Momentum

Potential

West Pharmaceutical Non-GAAP EPS of $1.96 beats by $0.27 revenue of $804.6M beats by $16.9M.

Thu Oct 23, 2025

$307.25 | +11.01%

Earnings

West Reports Third-Quarter 2025 Results. - Delivered solid growth across Proprietary Products and Contract Manufacturing Segments - - Achieved double-digit growth in HVP Components -- Strengthened executive leadership team including recently appointed CFO - Increases Full-Year 2025 Revenue and EPS Guidance - Third-Quarter Summary (comparisons to prior-year period)Net sales of Diluted EPS of Adjusted-diluted EPS of Full-year 2025 net sales guidance increased to a range of Full-year 2025 adjust

Thu Oct 23, 2025

$307.25 | +11.01%

Activity

Potential

Discover WST Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of WST. We're here to help you make informed investment decisions today.

FIND US ON

Receive our WST Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

WST Stock trends

WST Stock performance

WST Stock analysis

WST investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing WST

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing WST

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

WST Stock Analysis & IQ Rating | West Pharmaceutical

WST Stock IQ

WST Target Price

WST Risk Level

WST Analysts Opinion

WST Street Consensus

WST Performance Sentiment

WST Financial Health

Explore our WST Stock insights

Receive our WST Daily Alerts

WST Stock IQ

WST Street Consensus

WST Risk Level

Discover WST Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of WST. We're here to help you make informed investment decisions today.

Receive our WST Daily Alerts

WST Runner Alarm